PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study suggests way to fight therapy resistant leukemia by blocking DNA repair

2013-08-08
(Press-News.org) CINCINNATI – New research posted online by the Nature journal Leukemia suggests blocking part of a DNA repair complex that helps some types of leukemia resist treatment can increase the effectiveness of chemotherapy and enhance survival.

Scientists from Cincinnati Children's Hospital Medical Center report that their experimental combination treatment strategy – using a small molecular inhibitor along with chemotherapy – was particularly effective at stopping a stubborn leukemia called T-cell acute lymphoblastic leukemia, or T-ALL. The study involved laboratory cell lines of human leukemia and mouse models of the disease.

Initial remission rates for T-ALL with current treatments are about 90 percent, but the overall survival rate is between 60 and 70 percent.

"Although initial remission rates are high with available treatments, the disease comes back because of drug resistance that leads to relapse. There is an urgent need to develop new therapeutic strategies to combat refractory T-ALL and our study uncovers a way to enhance the effectiveness of chemotherapy," said Fukun Guo, PhD, study first author and a researcher in the Division of Experimental Hematology and Cancer Biology at Cincinnati Children's.

A key breakthrough in the research came when the scientists discovered something that was previously unknown – a molecular mechanism in the Fanconi anemia DNA repair pathway apparently makes T-ALL resistant to chemotherapy. This same pathway has been linked to drug resistance in other types of cancer, Guo said.

Chemotherapy drugs are often designed to kill off malignant cells by damaging their DNA until they transition to a programmed death mode called apoptosis. Some cancers are able to leverage molecular workarounds – such as DNA repair – to become treatment resistant. This has helped prompt the development of targeted molecular therapies to attack other components of cancerous cells – either as stand-alone therapies or to augment chemotherapy.

Fanconi anemia (FA) is a genomic instability syndrome caused by mutations inside a cluster of proteins normally responsible for DNA repair in cells. Mutation or silencing of FA genes is also associated with increased sensitivity to DNA damaging drugs. Guo and his fellow researchers worked under the premise that inhibiting the FA pathway and combining this with DNA damaging chemotherapy drugs might be a promising strategy for cancer therapy.

To block the FA repair pathway in leukemic cells, researchers tested the inhibition of a protein called mTOR (mammalian target of rapamycin). The protein plays a critical role in the growth and survival of mammalian cells – although disruptions in the mTOR molecular pathway are linked to tumor growth, chemotherapy resistance and poor prognoses in malignancies such as leukemia.

Initial testing of mTOR inhibition was achieved by direct deletion of the mTOR gene in mice. The scientists noticed that this caused significant down regulation, or silencing, of a protein called FANCD2 – a component of the FA repair pathway.

The scientists then tested three new mTOR inhibitors currently under development (pp242, AZD8055 and INK128) in combination with the chemotherapies AraC, Etoposide and Cisplatin to see how they affected laboratory lines of leukemia cells and mouse models of the disease. They compared the effectiveness of the combination treatments with just treating the leukemia by chemotherapy or inhibitors alone. Tests showed that combining mTOR inhibitors with chemotherapy was far more effective at treating leukemia than when the inhibitors or chemotherapy were used as stand-alone treatments.

In one example highlighted by the researchers, mouse models of T-ALL were treated either with a combination of mTOR inhibitor pp242 and the chemotherapy drug AraC, or they were treated with just AraC or pp242. Mice treated only with pp242 or AraC died from their leukemia within 80 days. Mice treated with pp242 and AraC showed significantly prolonged survival, with 75 percent surviving more than 100 days and 50 percent surviving about 175 days.

Although the researchers emphasized that laboratory results involving cell lines and mice do not necessarily translate to human treatment, they say their findings show that new mTOR inhibitors combined with chemotherapy could become a new treatment strategy for T-ALL. They also report that inhibition of the FA pathway coupled with chemotherapy maybe be useful for treating other types of cancer.

Guo and his collaborators continue their studies by establishing additional mouse models of leukemia that have been transplanted with patient cells of relapsed and refractory disease. They are testing combination treatment on the mice with mTOR inhibitors and a chemotherapy agent called AraG, which is currently in clinical use to treat T-ALL.

### Funding support for the study came from the National Institutes of Health (grants R01HL076712, R01CA157537, T32HL091805). Corresponding author Qishen Pang, PhD, of Cincinnati Children's, is supported by a Leukemia and Lymphoma Scholar award from the Leukemia and Lymphoma Society.

About Cincinnati Children's: Cincinnati Children's Hospital Medical Center ranks third in the nation among all Honor Roll hospitals in U.S. News and World Report's 2013 Best Children's Hospitals ranking. It is ranked #1 for cancer and in the top 10 for nine of 10 pediatric specialties. Cincinnati Children's is one of the top two recipients of pediatric research grants from the National Institutes of Health, and a research and teaching affiliate of the University of Cincinnati College of Medicine. The medical center is internationally recognized for improving child health and transforming delivery of care through fully integrated, globally recognized research, education and innovation. Additional information can be found at http://www.cincinnatichildrens.org. Connect on the Cincinnati Children's blog, via Facebook and on Twitter.


ELSE PRESS RELEASES FROM THIS DATE:

UNC-Malawi cancer pathology laboratory is a model for Sub-Saharan Africa

2013-08-08
Since 2011, the University of North Carolina has partnered with the government of Malawi to establish a pathology laboratory in the nation's capital, building on an existing decades-long collaboration. The laboratory has provided an invaluable service to patients and has also built capacity at a national teaching hospital, according to an analysis of the first 20 months of operation published (date) online by PLOS ONE. "A robust platform for cancer care and research now exists in a setting where it did not previously, and can serve as a model for similar interventions ...

Use digital signal processing engineering to prevent a flash crash, says NJIT prof

2013-08-08
NJIT Associate Professor Ali Akansu, PhD, wants to prevent another flash crash on Wall Street. An electrical and computing engineer who is an expert in the relatively new field of adapting signal processing to strengthen the security of finance markets, he fights to be heard. Among his weapons are frequent talks to colleagues at IEEE events. He believes that by using new technology—like digital signal processing (DSP) engineering--another flash crash, like the one in 2010 that almost destroyed world-wide financial markets, need never happen again. "There are DSP engineering ...

Nutritional values established in 3 new, high-energy protein ingredients fed to weanling pigs

2013-08-08
URBANA, Ill. – The use of soybean meal in diets fed to weanling pigs is limited due to the presence of anti-nutritional factors that young pigs can't tolerate. Therefore, other sources of protein, such as fish meal and plasma, are used in nursery pig diets. But there are other ingredients available to producers as well. Researchers at the University of Illinois have determined the nutritional value of three new protein products that have recently become available as feed ingredients for pigs. Hans H. Stein, a U of I professor of animal sciences, and his team measured ...

Robot treats brain clots with steerable needles

2013-08-08
Surgery to relieve the damaging pressure caused by hemorrhaging in the brain is a perfect job for a robot. That is the basic premise of a new image-guided surgical system under development at Vanderbilt University. It employs steerable needles about the size of those used for biopsies to penetrate the brain with minimal damage and suction away the blood clot that has formed. The system is described in an article accepted for publication in the journal IEEE Transactions on Biomedical Engineering. It is the product of an ongoing collaboration between a team of engineers ...

Pass the salt: Common condiment could enable new high-tech industry

2013-08-08
CORVALLIS, Ore. – Chemists at Oregon State University have identified a compound that could significantly reduce the cost and potentially enable the mass commercial production of silicon nanostructures – materials that have huge potential in everything from electronics to biomedicine and energy storage. This extraordinary compound is called table salt. Simple sodium chloride, most frequently found in a salt shaker, has the ability to solve a key problem in the production of silicon nanostructures, researchers just announced in Scientific Reports, a professional journal. By ...

Chocolate may help keep brain healthy

2013-08-08
MINNEAPOLIS – Drinking two cups of hot chocolate a day may help older people keep their brains healthy and their thinking skills sharp, according to a study published in the August 7, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study involved 60 people with an average age of 73 who did not have dementia. The participants drank two cups of hot cocoa per day for 30 days and did not consume any other chocolate during the study. They were given tests of memory and thinking skills. They also had ultrasounds tests to measure ...

Dementia risk tied to blood sugar level, even with no diabetes

2013-08-08
SEATTLE -- A joint Group Health–University of Washington (UW) study in the New England Journal of Medicine has found that higher blood sugar levels are associated with higher dementia risk, even among people who do not have diabetes. Blood sugar levels averaged over a five-year period were associated with rising risks for developing dementia, in this report about more than 2,000 Group Health patients age 65 and older in the Adult Changes in Thought (ACT) study. For example, in people without diabetes, risk for dementia was 18 percent higher for people with an average ...

5-year olds choose to 'play nice' based on other kids' reputations

2013-08-08
Five-to-six-year olds are more likely to be kind to peers after observing them interacting with other children in positive ways, suggesting that children establish a sense of their peers' 'reputation' early in life. The results are published August 7 in the open access journal PLOS ONE by Kenji Onishi and colleagues from Osaka University, Japan. The researchers observed kindergarteners' day-to-day behavior and found that bystanders in a playground were more likely to offer an object or help a child whom they had seen being helpful to another child. Children were more ...

Belief in precognition increases sense of control over life

2013-08-08
People given scientific evidence supporting our ability to predict the future feel a greater sense of control over their lives, according to research published August 7 in the open access journal PLOS ONE by Katharine Greenaway and colleagues from the University of Queensland, Australia. One group of study participants read a paragraph stating that researchers had found evidence supporting the existence of precognition, while another group read a related paper that refuted these findings. Both papers were published in the same issue of a scientific journal. On a subsequent ...

Angry opponents seem bigger to tied up men

2013-08-08
A physical handicap like being tied down makes men over-estimate an opponent's size and under-estimate their own, according to research published August 7 in the open access journal PLOS ONE by Daniel Fessler and Colin Holbrook from the University of California, Los Angeles. Participants who were tied down in a chair envisioned an angry man in a picture as being taller than when they made the same type of guess while simply sitting in the chair without being restrained. In a second test where they were asked to state their own height based on visual marks on a wall, ...

LAST 30 PRESS RELEASES:

Two thirds of reproductive-aged women have at least one modifiable risk factor for birth defects, study reveals

Boosting the neuroglia as a therapeutic strategy for brain disorders

Computational neurogenomics revolution unlocks personalized treatments for brain disorders worldwide

Psychedelics researcher reveals how MDMA and LSD transform human connectedness

Making low-fertility rats fertile by changing the treatment interval

Common painkillers linked to antibiotic resistance

Teachers' depression, anxiety and stress at three times the national norm: new study

Common cold may protect against COVID-19 according to National Jewish Health researchers

New project to improve information retrieval for lifelong learning

New method probes cancer cell messengers that weaken immune system

VCs backed Black founders after BLM – but it didn’t last

A new tool to track infant development, starting at just 16 days old

Generative AI uncovers undetected bird flu exposure risks in Maryland emergency departments

High concentration THC associated with schizophrenia, psychosis, and other unfavorable mental health outcomes

Mediterranean diet with fewer calories and exercise lowers diabetes risk by 31%

Mediterranean diet combined with calorie reduction and exercise may reduce risk of type 2 diabetes by nearly one-third

Researchers to gather next week for 10th Peer Review Congress

Rising deep-ocean oxygen levels opened up new marine habitats, spurred speciation

Melanie Cocco named as next Editor-in-Chief of Biophysical Reports

Polysubstance involvement in youth opioid overdoses increases with age

Brain’s blood flow could change how we understand and treat Alzheimer’s

Mount Sinai scientists create AI-powered tool to improve cancer tissue analysis

Scientists discover how cells use a secret weapon to fight off some pathogens

Research uncovers why IBD causes blood clots—and how to prevent them

Having a sense of purpose may protect against dementia

Trump shooting and Biden exit flipped social media from hostility to solidarity – study

New discovery of wild cereal foraging – a precursor to agriculture – far from the fertile crescent

Flamingos reveal their secret to ageing

An early sign of cognitive decline in aging populations

Neural activity linked to self-preoccupied thinking

[Press-News.org] Study suggests way to fight therapy resistant leukemia by blocking DNA repair